Article
Estrogen receptor (ER) gene polymorphism may predict the bone mineral density response to raloxifene in postmenopausal women on chronic hemodialysis.
Renal failure - 1 Jan 2005
Heilberg Ita Pfeferman, Hernandez Eddy, Alonzo Evelyn, Valera Raquel, Ferreira Larissa Gorayb, Gomes Samirah Abreu, Bellorin-Font Ezequiel, Weisinger Jose R
Abstract excerpt
The estrogen receptor (ER) gene has been considered as a candidate genetic marker for osteoporosis, and PvuII and XbaI polymorphisms of the ERalpha gene have been associated with low bone mineral density (BMD). We investigated whether ER polymorphism could predict the response of BMD in 28 postmenopausal women on hemodialysis with marked osteopenia or osteoporosis, randomized to receive raloxifene, a selective...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
